Abiopharma

Natera - Exelixis and Natera to Collaborate on STELLAR-316, a Phase 3 Pivotal Trial of Zanzalintinib for Patients with Colorectal Cancer

Harmony Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

Rigel to Present at the 44th Annual J.P. Morgan Healthcare Conference

Inspire Medical Systems, Inc. - Inspire Medical Systems, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026

ENLIVEX (ENLV) Files Form 6-K

Alterity Therapeutics Limited (ATHE) Files Form 6-K

Johnson & Johnson - Johnson & Johnson SubmitsOTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration

Ethos and North American Collaborate to Offer Accumulation Indexed Universal Life Product

SAB BIO Strengthens Board of Directors with Appointment of New Chair and New Director

bioAffinity Technologies’ Laboratory Maintains Prestigious College of American Pathologists (CAP) Accreditation

Innovative Eyewear, Inc. Announces Record-Breaking 65% Annual Sales Growth in 2025 & Insider Buying Intent

Evaxion to present 2026 company milestones at Biotech Showcase conference in San Francisco next week

AbbVie to Host Full-Year and Fourth-Quarter 2025 Earnings Conference Call

Verrica Pharmaceuticals Announces First Patient Dosed in Phase 3 Program Evaluating YCANTH® (VP-102) for the Treatment of Common Warts

Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference